FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Herbert Karthaus

Research Profile

Disorders

Procedures

Anatomy

Prostate

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Diederik M Somford; Jean-Paul van Basten; Inge van Oort; J Alfred Witjes; Jurgen J Fütterer; Thomas Hambrock; Christina A Hulsbergen-van de Kaa; Herbert F M Karthaus; Jelle O Barentsz
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Grégoire Robert; Frank Smit; Tilly Aalders; Alexandre de la Taille; Daphne Hessels; Sander Jannink; Kees Jansen; Herbert F M Karthaus; Peter F A Mulders; Jack A Schalken
Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia.
Dieuwertje E G Kok; Moniek W M van de Luijtgaarden; Joep G H van Roermund; Oncko B van Vierssen Trip; Katja K H Aben; J Alfred Witjes; Ellen Kampman; Herbert F M Karthaus; Lambertus A L M Kiemeney
Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Herbert Karthaus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Diederik M Somford; Jean-Paul van Basten; Inge van Oort; J Alfred Witjes; Jurgen J Fütterer; Thomas Hambrock; Christina A Hulsbergen-van de Kaa; Herbert F M Karthaus; Jelle O Barentsz
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
Investigative radiology 2012;47(3):153-8.
2011: Grégoire Robert; Frank Smit; Tilly Aalders; Alexandre de la Taille; Daphne Hessels; Sander Jannink; Kees Jansen; Herbert F M Karthaus; Peter F A Mulders; Jack A Schalken
Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasia.
The Prostate 2011;71(15):1701-9.
2011: Dieuwertje E G Kok; Moniek W M van de Luijtgaarden; Joep G H van Roermund; Oncko B van Vierssen Trip; Katja K H Aben; J Alfred Witjes; Ellen Kampman; Herbert F M Karthaus; Lambertus A L M Kiemeney
Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.
World journal of urology 2011;29(5):695-701.
2011: P R van Dijk; A C Viddeleer; P C Weijerman; J A Witjes; Katja K H Aben; A Geboers; Herbert F M Karthaus; M Ploeg; J Th H van Berkel; E van Boven; L A L M Kiemeney
Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.
ISRN urology 2011;2011():458930.
2009: Joep G H van Roermund; Jean-Paul A van Basten; Lambertus A Kiemeney; Herbert F M Karthaus; J Alfred Witjes
Impact of obesity on surgical outcomes following open radical prostatectomy.
Urologia internationalis 2009;82(3):256-61.
2007: Inge van Oort; K Tomita; A van Bokhoven; M J G Bussemakers; Lambertus A L M Kiemeney; Herbert F M Karthaus; J Alfred Witjes; Jack A Schalken
The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
The Prostate 2007;67(13):1432-8.
2007: Paula M J Moonen; Gerard F M Merkx; Pim Peelen; Herbert F M Karthaus; Dominique Smeets; J Alfred Witjes
UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
European urology 2007;51(5):1275-80; discussion 1280.
2007: Martijn P M Q van Gils; Daphne Hessels; Onno van Hooij; Sander A Jannink; W Pim Peelen; Suzanne L J Hanssen; J Alfred Witjes; Erik B Cornel; Herbert F M Karthaus; Geert A H J Smits; Gerhard A Dijkman; Peter F A Mulders; Jack A Schalken
The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(3):939-43.
2004: Iman J Schultz; Lambertus A L M Kiemeney; Herbert F M Karthaus; J Alfred Witjes; Johannes L Willems; Dorine W Swinkels; Jacqueline M T Klein Gunnewiek; Jacques B de Kok
Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas.
Clinical chemistry 2004;50(8):1425-8.
2003: Daphne Hessels; Jacqueline M T Klein Gunnewiek; Inge van Oort; Herbert F M Karthaus; Geert J L H van Leenders; Bianca van Balken; Lambertus A L M Kiemeney; J Alfred Witjes; Jack A Schalken
DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.
European urology 2003;44(1):8-15; discussion 15-6.
1999: M J G Bussemakers; A van Bokhoven; Gerald W Verhaegh; F P Smit; Herbert F M Karthaus; Jack A Schalken; Frans M J Debruyne; N Ru; William B Isaacs
DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.
Cancer research 1999;59(23):5975-9.
1999: Erik B Cornel; Herbert F M Karthaus
Manual derotation of the twisted spermatic cord.
BJU international 1999;83(6):672-4.
1996: Y Tamimi; H G van der Poel; Herbert F M Karthaus; F M Debruyne; Jack A Schalken
A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.
British journal of cancer 1996;74(4):573-8.
1996: E te Slaa; J J Mooibroek; Theo M de Reijke; Herbert F M Karthaus; J W van Capelle; N T Gi; J J de la Rosette
Laser treatment of the prostate using the Urolase fiber: the Dutch experience.
The Journal of urology 1996;156(2 Pt 1):420-4; discussion 425.
1994: Jacqueline Vet; PP Bringuier; P J Poddighe; Herbert F M Karthaus; F M Debruyne; Jack A Schalken
p53 mutations have no additional prognostic value over stage in bladder cancer.
British journal of cancer 1994;70(3):496-500.
1994: R van Dijk; Herbert F M Karthaus
Ultrasonography of the spermatic cord in testicular torsion.
European journal of radiology 1994;18(3):220-3.
1994: R Umbas; William B Isaacs; PP Bringuier; H E Schaafsma; Herbert F M Karthaus; GO Oosterhof; F M Debruyne; Jack A Schalken
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Cancer research 1994;54(14):3929-33.
1993: Erik B Cornel; G A Smits; GO Oosterhof; Herbert F M Karthaus; F M Deburyne; Jack A Schalken; A Heerschap
Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy.
The Journal of urology 1993;150(6):2019-24.
1993: Y Tamimi; H G van der Poel; M M Denyn; R Umbas; Herbert F M Karthaus; F M Debruyne; Jack A Schalken
Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.
Cancer research 1993;53(22):5512-6.
1993: PP Bringuier; R Umbas; H E Schaafsma; Herbert F M Karthaus; F M Debruyne; Jack A Schalken
Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors.
Cancer research 1993;53(14):3241-5.
1993: J J de la Rosette; Herbert F M Karthaus; E E Schaafsma; R van Dijk
Work-up and management of incidentally found hypoechoic lesions of the testis.
Urologia internationalis 1993;51(1):23-7.
1992: R Umbas; Jack A Schalken; Tilly W Aalders; B S Carter; Herbert F M Karthaus; H E Schaafsma; F M Debruyne; William B Isaacs
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Cancer research 1992;52(18):5104-9.
1992: J J de la Rosette; Herbert F M Karthaus; F M Debruyne
Ultrasonographic findings in patients with nonbacterial prostatitis.
Urologia internationalis 1992;48(3):323-6.
1992: J J de la Rosette; M R Hubregtse; Herbert F M Karthaus; F M Debruyne
Results of a questionnaire among Dutch urologists and general practitioners concerning diagnostics and treatment of patients with prostatitis syndromes.
European urology 1992;22(1):14-9.
1992: J J de la Rosette; Herbert F M Karthaus; P E van Kerrebroeck; T de Boo; F M Debruyne
Research in 'prostatitis syndromes': the use of alfuzosin (a new alpha 1-receptor-blocking agent) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities.
European urology 1992;22(3):222-7.
1988: Jack A Schalken; Ans M W van den Ouweland; F M Debruijne; Herbert F M Karthaus; Wim J M Van De Ven
Oncogenes and urological malignancies: implications for the future.
Urological research 1988;16(5):333-9.
1987: Herbert F M Karthaus; W F J Feitz; A P vd Meijden; Jack A Schalken; J L Beck; B T Hendriks; PH Jap; G Peter Vooijs; F M Debruyne; Frans C S Ramaekers
Multidisciplinary evaluation of rat renal cell carcinoma.
In vivo (Athens, Greece) 1987;1(6):335-41.
1987: Herbert F M Karthaus; W F J Feitz; Frans C S Ramaekers; J L Beck; B T Hendriks; Jack A Schalken; K H Kurth; PH Jap; F M Debruyne
Multiparameter analysis of four human renal cell carcinoma xenografts in nude mice.
In vivo (Athens, Greece) 1987;1(6):327-34.
1987: Herbert F M Karthaus; M J G Bussemakers; Jack A Schalken; K H Kurth; W F J Feitz; F M Debruyne; Henri P J Bloemers; Wim J M Van De Ven
Expression of proto-oncogenes in xenografts of human renal cell carcinomas.
Urological research 1987;15(6):349-53.
1986: W F J Feitz; Herbert F M Karthaus; H L Beck; C Romijn; A P van der Meyden; F M Debruyne; G Peter Vooijs; Frans C S Ramaekers
Tissue-specific markers in flow cytometry of urological cancers. II. Cytokeratin and vimentin in renal-cell tumors.
International journal of cancer. Journal international du cancer 1986;37(2):201-7.
1986: F M Debruyne; GO Oosterhof; Herbert F M Karthaus
Percutaneous removal of stones in the kidney.
Acta urologica Belgica 1986;54(3):245-55.
1986: Herbert F M Karthaus; Jack A Schalken; W F J Feitz; F M Debruyne; Peter de Haan; Henri P J Bloemers; Wim J M Van De Ven
Expression of the human fes cellular oncogene in renal cell tumors.
Urological research 1986;14(3):123-7.